Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Flora Growth Corp (FLGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $156
1 Year Target Price $156
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -90.06% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 13.60M USD | Price to earnings Ratio - | 1Y Target Price 156 |
Price to earnings Ratio - | 1Y Target Price 156 | ||
Volume (30-day avg) 2 | Beta 1.97 | 52 Weeks Range 15.15 - 82.29 | Updated Date 08/15/2025 |
52 Weeks Range 15.15 - 82.29 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -34.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-01 | When - | Estimate 0.14 | Actual -4.38 |
Profitability
Profit Margin -24.96% | Operating Margin (TTM) -17.34% |
Management Effectiveness
Return on Assets (TTM) -30.57% | Return on Equity (TTM) -212.2% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 19902050 | Price to Sales(TTM) 0.26 |
Enterprise Value 19902050 | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 0.38 | Enterprise Value to EBITDA -1 | Shares Outstanding 578683 | Shares Floating 504882 |
Shares Outstanding 578683 | Shares Floating 504882 | ||
Percent Insiders 12.54 | Percent Institutions 4.06 |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp. was founded in 2019 and went public in 2021. It is a vertically integrated cannabis company focused on building a global brand portfolio through low-cost cultivation and strategic acquisitions.
Core Business Areas
- Flora Pharma: Focuses on the development and distribution of cannabis-based pharmaceutical products, including over-the-counter medications and prescription drugs.
- Flora Beauty: Develops and markets a range of cannabis-infused beauty and skincare products.
- Flora Food and Beverage: Concentrates on producing and distributing cannabis-infused food and beverage products.
- House of Brands: Includes a portfolio of lifestyle brands focused on various consumer products and experiences.
Leadership and Structure
Luis Merchan serves as Chairman and CEO. The company has a board of directors overseeing strategic direction and a management team responsible for day-to-day operations. Organizational structure supports vertically integrated operations.
Top Products and Market Share
Key Offerings
- Mind Naturals: Skincare brand focused on leveraging natural ingredients. Market share data is not readily available publicly. Competitors include The Body Shop, Kiehl's, and other natural skincare brands.
- JustCBD: CBD products. JustCBD generated approximately $30 million in revenue in 2022 (prior to acquisition). Competitors include Charlotte's Web (CW) and CBDMD.
- Various Cannabis Flower Strains: Cultivation and sales of various cannabis flower strains, primarily in Colombia. Market share varies by region and is not readily available. Competitors are other licensed cannabis producers in Colombia and globally.
Market Dynamics
Industry Overview
The cannabis industry is experiencing significant growth, driven by increasing legalization, rising consumer demand, and expanding medical applications. It's also highly regulated and subject to evolving legislation.
Positioning
Flora Growth positions itself as a vertically integrated, low-cost producer with a focus on international markets, leveraging its Colombian cultivation operations. Its competitive advantage lies in its cost structure and potential for economies of scale.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars. Flora Growth is positioned to capture a portion of this market through its diverse product offerings and international expansion.
Upturn SWOT Analysis
Strengths
- Low-cost cultivation capabilities in Colombia
- Vertically integrated operations
- Diverse product portfolio
- International expansion strategy
- Experienced management team
Weaknesses
- Relatively small market share compared to larger competitors
- Dependence on regulatory approvals and changes
- Limited brand recognition in some markets
- Historical losses and negative cash flow
- High SG&A relative to revenue
Opportunities
- Further legalization of cannabis in key markets
- Expansion into new international markets
- Development of innovative cannabis-based products
- Strategic partnerships and acquisitions
- Increased consumer awareness and acceptance of cannabis
Threats
- Intense competition from established players
- Fluctuations in cannabis prices
- Changes in regulations and government policies
- Economic downturns and decreased consumer spending
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Canopy Growth Corporation (CGC)
- Tilray Brands, Inc. (TLRY)
- Curaleaf Holdings, Inc. (CURLF)
Competitive Landscape
Flora Growth faces stiff competition from larger, more established players. Its low-cost production and international focus are key differentiators. Overal FLGC's market share is very small comparatively.
Major Acquisitions
JustCBD
- Year: 2022
- Acquisition Price (USD millions): 30
- Strategic Rationale: Acquisition of JustCBD significantly increased Flora's revenue and expanded its CBD product offerings, providing immediate market access and brand recognition.
Growth Trajectory and Initiatives
Historical Growth: Requires historical data to analyze specific past growth trends.
Future Projections: Analyst projections for Flora Growth's future growth are not readily available in this context but can be found through financial news platforms.
Recent Initiatives: Recent initiatives include strategic acquisitions (e.g., JustCBD), expansion into new markets, and product development efforts.
Summary
Flora Growth Corp. is a vertically integrated cannabis company with operations focused on low-cost cultivation and strategic brand acquisitions. While they have a diversified portfolio and expansion initiatives, they face strong competition and have historically struggled with profitability. Key strengths include their Colombian operations, but challenges remain in scaling operations and achieving sustained positive financial performance. Investors should monitor their ability to integrate acquisitions and achieve profitability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Financial news sources
- Industry reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data may not be precise and can vary based on different sources and methodologies.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Clifford A. Starke | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com | ||
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.